Related Experiment Video
Updated: May 5, 2026

Measurement of Antibody Effects on Cellular Function of Isolated Cardiomyocytes
Published on: March 8, 2013
Dilated cardiomyopathy and myocarditis: monoclonal antibodies to diseased heart tissues
1Department of Cellular and Molecular Sciences, St. George's Hospital Medical School, London, UK.
Insights
Researchers investigated contractile protein changes in dilated cardiomyopathy (DCM). No DCM-specific antibodies were found, and key protein alterations were not unique to DCM, suggesting further research is needed for this heart condition.
Area of Science:
- Cardiology
- Molecular Biology
- Immunology
Background:
- Dilated cardiomyopathy (DCM) is a complex heart condition characterized by impaired cardiac function.
- Understanding molecular alterations in contractile proteins is crucial for diagnosing and treating DCM.
Purpose of the Study:
- To identify abnormal contractile protein antigens and expression changes in DCM using monoclonal antibodies.
- To assess the specificity of these antibodies for DCM.
Main Methods:
- Monoclonal antibodies were generated against heart extracts from DCM and myocarditis patients.
- Antibody specificities were evaluated on cardiac tissue sections from DCM patients.
- A panel of antibodies targeting myosin heavy chain beta, actin, and troponin-I was characterized.
Main Results:
- No DCM-specific antibodies were identified among over 1500 clones.
- No significant alterations in the distribution of targeted contractile protein epitopes were observed in DCM.
- An increase in myosin heavy chain beta in atrial myocytes was noted in DCM, but also in other conditions, indicating it's not specific to DCM.
Conclusions:
- The study did not find specific antibody markers for DCM.
- Observed alterations in myosin heavy chain beta are not specific to DCM.
- Further investigation with well-defined monoclonal antibodies is recommended to elucidate DCM's underlying molecular defects.
Abstract:
This study looked for the presence of abnormal contractile protein antigens and alterations in contractile protein expression in dilated cardiomyopathy (DCM). Monoclonal antibodies were raised to extracts from hearts removed at cardiac transplantation from two patients with dilated cardiomyopathy (DCM), and one with myocarditis. The specificities of the antibodies were assessed on cryostat sections from eight hearts with DCM. Although an extensive search was made for DCM-specific antibodies among over 1500 clones, none were found. However, a panel of antibodies was prepared and characterized, including antibodies to human adult myosin heavy chain beta, actin and troponin-I, which were selected for their value as reagents for immunocytochemical studies on cardiac, skeletal and smooth muscle. No significant alteration in the distribution of the epitopes recognized by these antibodies was found in DCM although more atrial myocytes in patients with DCM contained myosin adult heavy chain-beta. As a similar increase was found in atria from patients with other diseases who had a normal filling pressure, it was concluded that this alteration was unrelated to filling pressure, and was not specific for DCM. Further work with well defined monoclonal antibodies to other cardiac components in DCM could be useful in defining the alterations which lead to the functional defects in DCM and other cardiac diseases of unknown cause.
Related Concept Videos
Myocarditis I: Introduction
Myocarditis II: Clinical Features and Diagnostic Tests
Myocarditis III: Medical Management
Cardiomyopathy I: Introduction and Classification
Cardiomyopathy II: Dilated Cardiomyopathy
Cardiomyopathy IV: Restrictive Cardiomyopathy

